Evidence map›Paper›PMID 11071951›Full record

ArticleNucleic acids research2000

A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans.

M K Chaveroche, J M Ghigo, C d'Enfert

Abstract read
In one paragraph

Article in Nucleic acids research, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 222 papers.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

222 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Plasmid mutation rates scale with copy number.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. mBio · 2025
    Article
  7. Article
  8. Vat-Mediated Mucus Penetration Enables Genotoxic Activity ofInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. mBio · 2025
    Article
  11. Article
  12. TccP4: a novel effector identified in theMicrobiology spectrum · 2025
    Article
  13. Review
  14. Article
  15. RES-Xre toxin-antitoxin locusEmerging microbes & infections · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M K ChaverocheUnité de Physiologie Cellulaire and Unité des Membranes Bactériennes, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex 15, France.
J M Ghigo
C d'Enfert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The construction of mutant fungal strains is often limited by the poor efficiency of homologous recombination in these organisms. Higher recombination efficiencies can be obtained by increasing the length of homologous DNA flanking the transformation marker, although this is a tedious process when standard molecular biology techniques are used for the construction of gene replacement cassettes. Here, we present a two-step technology which takes advantage of an Escherichia coli strain expressing the phage lambda Red(gam, bet, exo) functions and involves (i) the construction in this strain of a recombinant cosmid by in vivo recombination between a cosmid carrying a genomic region of interest and a PCR-generated transformation marker flanked by 50 bp regions of homology with the target DNA and (ii) genetic exchange in the fungus itself between the chromosomal locus and the circular or linearized recombinant cosmid. This strategy enables the rapid establishment of mutant strains carrying gene knock-outs with efficiencies >50%. It should also be appropriate for the construction of fungal strains with gene fusions or promoter replacements.

Indexed as

Aspergillus nidulansCosmidsDNA, FungalFungal ProteinsGene TargetingRecombination, GeneticTrehalaseDNA, FungalFungal ProteinsTrehalase

Identifiers

PMID11071951
PMCPMC113889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.